Iridian Asset Management LLC Avadel Pharmaceuticals PLC Transaction History

Iridian Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$12.55 - $17.22 $233,103 - $319,844	18,574 Added 34.75%	72,025 $1.22 Million
Q4 2023 Jan 26, 2024	BUY	$9.64 - $14.59 $75,818 - $114,750	7,865 Added 17.25%	53,451 $754,000
Q2 2023 Aug 09, 2023	BUY	$8.48 - $16.48 $386,569 - $751,257	45,586 New	45,586 $751,000
Q2 2022 Jul 29, 2022	BUY	$1.07 - $6.95 $32,100 - $208,500	30,000 New	30,000 $73,000
Q1 2022 May 02, 2022	SELL	$5.46 - $8.29 $121,643 - $184,692	-22,279 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$7.34 - $11.18 $265,869 - $404,961	-36,222 Reduced 61.92%	22,279 $180,000
Q3 2021 Nov 10, 2021	SELL	$6.49 - $9.91 $1.12 Million - $1.71 Million	-172,572 Reduced 74.68%	58,501 $573,000
Q2 2021 Aug 11, 2021	SELL	$6.73 - $9.05 $87,456 - $117,604	-12,995 Reduced 5.32%	231,073 $1.56 Million
Q1 2021 May 11, 2021	SELL	$6.61 - $10.07 $672,230 - $1.02 Million	-101,699 Reduced 29.41%	244,068 $2.21 Million
Q4 2020 Feb 08, 2021	BUY	$5.03 - $7.95 $938,432 - $1.48 Million	186,567 Added 117.19%	345,767 $2.31 Million
Q2 2020 Aug 10, 2020	BUY	$7.25 - $11.75 $714,850 - $1.16 Million	98,600 Added 162.71%	159,200 $1.29 Million
Q1 2020 May 11, 2020	SELL	$4.06 - $10.64 $1.01 Million - $2.66 Million	-249,869 Reduced 80.48%	60,600 $481,000
Q4 2019 Feb 03, 2020	BUY	$3.34 - $7.7 $1.04 Million - $2.39 Million	310,469 New	310,469 $2.34 Million

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $662M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Iridian Asset Management LLC with notifications on news.